收录16421种疾病

扫一扫官方微信
关注更多健康资讯

问专家

提建议

回顶部

您所在的位置: 久久健康网> 疾病百科> 疾病症状> 眼眶肉瘤

罕见的老年患者左眼眶横纹肌肉瘤1例

时间 : 2009-11-26 06:25:29 来源:journal.shouxi.net

[摘要]

  报道罕见的老年患者的左眼眶横纹肌肉瘤1例,表现为严重的眼球突出及真菌样生长的肿块。一位66岁的马来女性,鼻衄8mo后出现左眼严重的突眼和真菌样生长的肿块。活检显示小泡型横纹肌肉瘤的组织学特征。,首席医学

罕见的老年患者左眼眶横纹肌肉瘤1例首席医学网2009年03月17日11:07:41Tuesday中华临床医师杂志征稿内科临床新进展研讨班重症与血流动力学大会血液净化技术学习班医学类核心期刊征稿第六届世界中医药大会2009世界高血压大会第四届中国国际白血病急危重病护理交流会IOF亚洲骨质疏松班2009年中国药学大会医学影像学术交流会结直肠肛门外科会议口腔正畸学术会议征稿广东研究生学术论坛

作者:OmarMIsmaeel,MIbrahim作者单位:马来西亚吉兰丹,马来西亚理科大学医学院眼科

加入收藏夹

【摘要】  报道罕见的老年患者的左眼眶横纹肌肉瘤1例,表现为严重的眼球突出及真菌样生长的肿块。一位66岁的马来女性,鼻衄8mo后出现左眼严重的突眼和真菌样生长的肿块。活检显示小泡型横纹肌肉瘤的组织学特征。

【关键词】横纹肌肉瘤;成年人;眼眶

  Rhabdomyosarcoma(RMS)comesfromGreekwordsrhabdomeansrodshape,myomeansmuscle.ItwasfirstdescribedbyWeberin1854,butitwasStoutwhogaveclearhistologicaldefinition.Theyappearfromprimitivemusclecells[1].TheocularregionparticularlytheorbitalsofttissuesrepresentamajoranatomiclocationforRMS[2].

  OrbitalRMSisoneofthefewlifethreateningdiseasesseeninitiallybyophthalmologistandpromptdiagnosisandtreatmentcansavethelifeoftheaffectedpatient.RMSisthemostcommonsofttissuesarcomainthepediatricpopulation.Itaccountsfor5%ofallchildhoodcancerandforabout20%ofallmalignantsofttissuetumorThepleomorphictypeoccursmoreofteninadultsbuttheembryonalandalveolartypesmainlyoccurininfantsandchildren.TheheadandneckRMSusuallyappearinthefirstdecadeoflife.

  TheprimarysitesofRMSincludeheadandneckarea45%,trunk40%andextremities15%,about25%35%ofheadandneckRMSariseintheorbit.SeveraldistincthistologicalgroupshaveprognosticsignificanceincludingembryonalRMSwhichoccursin55%ofpatientswhereasthebotryoidvariantoccursin5%ofpatients,alveolarin20%andundifferentiatedin20%.Treatmentresponsesandprognosisvarywidelydependingonlocationandhistology.

  ThecauseofRMSisunknown.Thealveolarvariantisusuallyassociatedwithoneoftwochromosomaltranslocationsnamely2;13or1;13.TheseresultinfusionoftheDNAbindingdomainoftheneuromusculardevelopmentaltranscriptionfactorsencodedbyPAX3onchromosome2orPAX7onchromosome1.Theresultinghybridmoleculeisapotenttranscriptionactivator.Itisbelievedtocontributetothecancerousphenotypebyabnormallyactivatingorrepressingothergenes.

  Approximately87%ofpatientsareyoungerthan15yearsand13%areaged1521years.RMSrarelyaffectsadults.Twopeaksincidencestendtobeassociatedwithdifferentlocations;patientsage26yearstendtohaveheadorneckorGUtracttumors,whereasadolescent1418yearstendtohaveprimarytumorsinextremities,truncalorparatesticularlocation.Prognosiscanalsoberelatedtothesizeoftumors.Tumoursizemorethan5cmisassociatedwithworsesurvival.NodalinvolvementappearstobeanadverseprognosticfactorinbothadultandpediatricRMS,whilepresenceofmetastasisissignificantlyassociatedwithdeath[3].

  CASEREPORT

  A66yearoldMalayladypresentedwithhistoryoffrequentheavyepistaxisfromleftnostrilforabouteightmonthsassociatedwithmildswellingoflefteye.Theproptosisgraduallyincreasedinsizewithcompletelossofvisioninlefteye.Hergeneralhealthwaspoorandtherewassignificantlossofweight.

  Onocularexaminationthereisseverenonaxialproptosisoflefteyewithsevereconjunctivalchemosisandfungatingmasslesionpushingtheeyeforwardanddownward(Figure1).ThevisioninlefteyewasNPLandtheorbitwasfrozen.Neckexaminationrevealedbilateralpalpablemultiplelymphnodemassesatcervicalandsubmandibularregions.Therighteyewasnormal.AbiopsytakenfromthemassandhistopathologicalexaminationshowedRMSofalveolartype.CTscanshowedahugemassfillingtheleftorbitalcavitywithsomeofthemassprotrudedoutsidethecavity.Theleftglobeispushedoutsidefromitscavityanddistortedinshape.ThemassextendsintonasopharynxwithobliterationofbothfossaofRossenmullerandintoleftmaxillarysinusandbothnasalcavity,superiorlythemassinfiltratesintotheethmoidal,sphenoidaandfrontalsinusesandinvolvingthelefttemporallobe,suprasellaryregionandcavernoussinusesespeciallyonleftside.(Figure2).

  Thepatientwasstartedoncytotoxicchemotherapyintotwophases.InphaseoneshereceivedfourcyclesofAdriamycin60mg,Vincristine2mgandcyclophosphamide1.2mgandinFigure1Severefungatingmasswithnonaxialsevereproptosis secondphaseshereceivedfourcyclesofMesna,EtoposideandIfosfomide.Treatmentwascompletedover6monthduration.Subsequentlythepatientwaslosttofollowup.

  DISCUSSION

  RMScommonlyaffectschildrenandyoungadultbutextremelyrareinelderlypeople.Inadultpopulationtwothirdoftissuesarcomaariseintheextremities[4].OrbitalRMScompriseof7%ofallRMS[5]andaccountsfor1%3%ofbiopsiedorbitalmassesinallagegroupsandform4%6%ofbiopsiedorbitalmassesinchildren.

  OrbitalRMSisprimarilyadiseaseofyoungchildrenwithmeanageatdiagnosisof8years;howeveritcanoccuratanyage.Thereisslightpredilectionformaleswithroughlya5∶3maletofemaleratio.Thereappearstobenoracialpredispositionandthetumorisinvariablyunilateral.Mosttumorsareretrobulbarresultinginproptosisbutitcanarisefromextraconalspaceespeciallysuperiororsuperonasalarea[6].TheclassicalveolarRMSiscomposedofnetsofpoorlydifferentiatedcellswithcentrallossofcellularcohesionsurroundedbyaframeworksofdensefibrousseptatheseformingirregularalveolarspaces.Alveolartumorsaremorecommonamongadolescents,oftenariseintheextremitiesandcarryaworseprognosis.EmbryonalRMSisbyfarthemostcommonvariantfoundintheheadandneckregionincludingtheorbit.RMSarerareinpatientsolderthan40years,mostinthisagegroupareofthepleomorphicsubtypewithareportedmedianagerangeof5056years[7].In1962PorterFieldandZimmermanrefutedtheprevailingassumptionthatembryonalRMSoriginatefrompreformedmuscle.ItisnowwidelybelievedandacceptedthatembryonalRMSarisesfromundifferentiatedmesenchymalcellsthatpossessthecapacitytodifferentiateintostriatedmuscle.TheadultRMSarisesfromvoluntarymusclesandisextremelyraresincefullymaturemusclecellsarenotpronetomalignantchanges[8].PatientswithorbitalRMSgenerallypresentwithproptosisin80%100%andglobedisplacementin80%.Painisasymptomin10%ofcasesanditusuallyoccursinmoreadvancedcases.Ocularmotornerveinvolvementresultinophthalmoplegiabutrecoveryafterinitiationofchemotherapyisalmost100%duetoreductionoftumorsizethatresultinrelievecompressiononthenerve.Incontrasttoocularmotilitytheprognosisforvisualrecoveryismuchworsewhichisduetoopticatrophy[9].Visualimpairmentisusuallyminimaluntiltumorsbecomeadvanced.ConcerninganatomicallocationRMSintheorbitproducesearlyocularsymptomsandsignsascomparedtotumorsinthemoreoccultlocationsandthispermitsearlierrecognitionofthetumor.Inadditiontherearefewlymphaticchannelsintheorbitalareaandthereforeearlylymphnodemetastasisrarelyoccurs.

  Inadultsproptosistendstohaveslowercourseandrarelyattainsalargesize.Inregionswheremedicalcareisnotreadilyavailable,RMScanattainimmenseproportionsanddestroytheeyeandhencevisionasinourcase.CTandMRIformcentralpartinthediagnosisofRMSandusuallyappearisointenseorgivesslightlyhighersignalthantheextraocularmusclesandlowersignalthanfatonT1weightedimages,onT2weightedimagesthelesiongiveshighsignalwithrespecttomuscleandorbitalfat.OrbitalRMScaninvadeorbitalboneandextendintocranialcavity,metastasismainlytolungsandbones;regionallymphnodemetastasisisrare.DistantmetastasisfromRMSisusuallyfatalinspiteofintensivechemotherapyandsymptomatictreatment.

  In1972intergroupRMS(IRS)studywasestablishedtoincreaseknowledgeandtoimprovetherapeuticresultsforRMSfromalllocations.Fourconsecutiveclinicaltrialshadbeenconductedandreported.AstagingclassificationofRMSemployedbyIRS,brieflygrouponeisdefinedaslocalizeddiseasecompletelyresected;grouptwo,microscopicdiseaseremainingafterbiopsy,groupthreeisgrossresidualdiseaseremainingafterbiopsy,groupfourisdistantmetastasispresentatonset.Thisclassificationcanassistinselectingtreatmentandinpredictingprognosis.ThisclassificationcanalsobeappliedtocasesoforbitalRMS.

  Untillate1960sorbitalexenterationwasgenerallyconsideredtobethetreatmentofchoicefororbitalRMS.HoweverthemortalityrateforpatientswithorbitalRMScontinuedtobegreaterthan70%inearly1970s.Itwasgraduallyrecognizedthatorbitalexenterationdidnotprovideaffectedpatientswithabetterprognosisandtherewasagraduallytrendtowardtreatmentwithlimitedbiopsyfollowedbyvariousregimensofirradiationandchemotherapy.Hence,orbitalexenterationisrarelyperformedasprimarytreatmenttoday.Itmaybejustifiedforextremelyadvanceddiseasethathaddestroyedtheeyeasfrequentlyseeninthirdworldcountries.Inmedicallyadvancedcountriesitstillemployedforsomeaggressivetumorsthathavebeenresistanttoirradiationandchemotherapy.

  Inlate1960sandearly1970ssystemicchemotherapywasincorporatedintoprotocolsfortreatmentofRMS.Thiswasusuallycombinedwithradiotherapywithcontinuedsuccess.TheagentsemployedwereVincristineandActinomycinD.In1979areviewoforbitalRMStreatedwithcombinedsurgery,irradiationandchemotherapydemonstratedcontroloftheprimarytumorandsalvageoftheeyeinover90%ofcases.

  ThelatestmanagementofRMSshouldincludeanycombinationofsurgery,irradiationandchemotherapy.Surgerycanbedonebycompleteornearcompletesurgicalremovalwhenthatcanbeachievedwithoutmajordamagetovitalstructuresliketheopticnerveandextraocularmuscles.Irradiationisusedasadjuncttosurgeryorchemotherapyfortumorrecurrenceafterstandardirradiationandchemotherapyhavefailedtocontrolthetumoralthoughexternalbeamirradiationhasbeenemployedinsuchcasesimplantbrachytherapyusingaspeciallydesignedradioactiveplaquehasbeenrarelyused.

  OrbitalRMShasveryfavorableoutcomewithActinomycinDandVincristine,ithasbeenshownbylateststudythatadditionofIfosfomideandEtoposidecanimproveoutcome.

  Systemicchemotherapyisconsideredtheonlytherapeuticoptionforpatientspresentingwithwidelymetastaticdiseaseorwithlocallyadvanceddiseasenotamenabletosurgeryorradiotherapy[10].Forthemajorityofthesepatientscytotoxicchemotherapyshouldberegardedaspalliativealthoughinsmallsubsetofpatientslongtermsurvivalmaybeachieved.Combinationofchemotherapymayproducehigherresponserate.Recentserieshavereportedimprovementsinthe5yearsurvivalratefrom5%to15%withlocaltherapyaloneto47%to62%withmultimodaltherapy.

  TheprognosisfororbitalRMShasimprovedgreatlyinrecentyears.FactorsthatappearresponsibleforbetterprognosisforRMSinorbitalregionincludethemorefavorableanatomicallocation,theearlierstageofthediseaseatthetimeofdiagnosis,morefavorabletumormorphologyandperhapspatientage.

  Absenceoflivermetastasis,youngageandhistopathologygradewereidentifiedasfavorablefactorsforresponsetochemotherapy,whilepresenceofbonemarrowmetastasiswasfoundtobeanindependentcauseofadverseprognosticfactor.NodalinvolvementappearstobeanadverseprognosticfactorinbothpediatricandadultRMS.Areviewof1,415patientswithoutdistantmetastasesinIRSIandIRSIIrevealeda10%incidenceofclinicalnodaldiseaseatdiagnosisanda14%incidenceofpathologiclymphaticmetastasesatresection.Nodalinvolvementwasparticularlycommoninpatientswithgenitourinarytracttumors(prevalence24%41%)andextremitytumors(12%),andthe3yearsurvivalratewithlocalregionaldiseasewas45%,comparedwith75%withlocalizeddisease.

  Tumormorphologyalsoappearstobeanimportantprognosticindicator,withEmbryonalRMSthemostcommontypeintheorbitcarryingmorefavorableprognosis.AlveolarRMSinwhichtranslocationexistbetweentheFKHRgenelocusandeitherPAX3orPAX7thusresultinginfusionproteinwhichisassociatedwithbetteroutcome.Metastaticdiseaseatpresentationisstronglyassociatedwithpoorprognosis.Asinourcase.Despitetherecentuseofmultimodaltherapytheprognosisinolderpatientsappearstobeworsethaninchildren.Withoverallresponseratewas82%.

  Increasetumorsizewasinverselyrelatedtoprognosis.The5yearsurvivalratesforpatientswithtumorslessthan5cm,510cm,andmorethan10cmwere60%,14%and0%respectively.The5yearsurvivalofthosewithorbitalalveolarRMSwas74%andembryonalRMSwas94%[11].Theembryonalcelltypeconstitutes80%oforbitaltumors.

  Femalepatientshadahigher5yearsurvivalratethanmalepatientsbutthedifferencewasnotstatisticallysignificant,thereappearedtobeanassociationbetweenfemalegenderswithcompleteresponsetochemotherapy.TheSurvivalrateaftertreatmentofRMSatallsiteshasimprovedfrom25%in1970to70%in1991.

  OrbitalRMShasbeenrecognizedtodisplaybetterlifeprognosisthanRMSatothersite,thetumorsdisplaystrongtendencyforlocalinvasion,localrecurrenceandhematogenousandlymphaticmetastasis.

  FerrarieevaluatedthetreatmentoutcomesforadultpatientswithRMSandconfirmtherelativelypoorlongtermoutcomes.Withradioimagingstudieslargetumorsappearedaslesswelldefinedsofttissuemasseswithbonedestructionorinvasionofsurroundingstructures.ItisstillpossiblehowevertodetectbonnyinvasionbyvirtueofdestructionofbonemarrowsignalonMRIespeciallywithadministrationofcontrast.

  Aftertreatmentisinstitutedcrosssectionalimagingcanbeusedtoobjectivelymonitortumorsregressionorresidualorrecurrentdisease.RMSmayoccurasmetastasistoorbitfromdistantsiteandevenafteryearsoftreatmentwhichisextremelyrare[12].5yearsurvivalrateincreasedfrom55%IRS1to71%IRS2andIRS4.

  Truncalandextremitytumorsaremorecommoninadults,andtherelativeproportionofpleomorphictumorsincreaseswithage.ThelatestseriesfromMemorialSloanKettering,therelativeproportionofextremityandpleomorphictumorsincreasedwithage,andsurvivaldecreasedwithincreasingageinbothunivariateandmultivariateanalyses.

  CONCLUSION

  RMSisprimarilyadiseaseofchildrenandyoungadultsbutcanoccurrarelyinelderlypeoplesohighindexofsuspicionisrequiredtoestablishearlyandcorrect.Diagnosisandinitiationofappropriatetreatmentwithchemotherapy,surgeryandradiotherapybeforemetastasismakeagreatdifferenceinsavinglivesofthesepatients.

【参考文献】  1CripeTP,GrossS,WindleML,BergstromSK,PetryPD,CoppesMJ.Rhabdomyosarcoma.emedicine2006;4:110  2ShieldsJA,ShieldsC.Rhabdomyosarcoma:reviewfortheophthalmologist.SurvOphthalmol2003;48(1):3957  3EsnaolaNF,RubinBP,BaldiniHE,VasudevanNBA,DemetriGD,FletcherCDM,SingerS.Responsetochemotherapyandpredictorsofsurvivalinadultrhabdomyosarcoma.AnnSurg2001;234(2):215223  4MachlederDJ,BanikR,RosenbergRB,ParikhSR.AnunusualcaseofRMSpresentingasorbitalapexsyndrome.IntJPediatrOtorhinolaryngol2005;69(2):249254  5SohaibSA,MoseleyL,WrightJE.OrbitalRhabdomyosarcomatheRadiologicalcharacteristics.ClinRadiol1998;53(5):357362  6MafeeMF,PaiE,PhilipB.RhabdomyosarcomaoftheorbitevaluationwithMRImigingandCT.RadiolClinNorthAm1998;36(6):12151227  7ManuchaV,CastellaniR,SunCC.AlveolarRhabdomyosarcomaoftheparanasaalsinusesina57yearoldwomanwith1:16translocation.IntJSurgPathol2006;14(3):238242  8MauryaOPS,PatelR,ThakaurV,SinghR,KumarM,EmbryonalRMSoftheorbitacasereport.IntOphthalmolClin1990;38(4):202204  9ShindlerKS,LiuGT,WomerRB.Longtermfollowupandprognosisoforbitalapexsyndromeresultingfromnasopharyngealrhabdomyosarcom.AmJOphthalmol2005;140(2):236241  10KaravasilisV,SeddonBM,AshleyS,ALMuderisO,FisherC,JudsonI.Significantclinicalbenefitoffirstlinepalliativechemotherapyinadvancedsofttissuesarcoma:retrospectiveanalysisandidentificationofprognosticfactorsin488patients.Cancer2008;112(7):15851591  11ShieldsCL,ShieldsJA,HonavarSG,DemirciH.Clinicalspectrumofprimaryophthalmicrhabdomyosarcom.Ophthalmology2001;108(2):22842292  12SimpsonJL,AlfordMA,CarterKD,KeechRV.MetastaticRMSpresentingasanisolatedlateralrectusrestriction.JPediatrOphthalmolStrabismus1999;36(2):9091

请您在下面输入常用的Email地址、职业以便我们定期通过邮箱发送给您最新的相关医学信息,感谢您浏览首席医学网!

邮箱:职业:

分享到:

更多文章>> 与“罕见的老年患者左...”相似的文章

更多>>

眼眶肉瘤疾病

早期x线摄片眼眶可能未有何变化,晚期则可有眼眶扩大和(或)伴有骨质破坏。 头颅CT检查可了解肿瘤情况,应用加造影剂的CT和MRI检查,可较好地显示肿瘤的部位、体积、边缘及其与周围组织的关系。 其它的检查方... 详细

专家咨询

王强

主任医师 副教授

擅长:胸外科 [详情]

向TA提问

倪幼方

主任医师 副教授

擅长:各种心血管 [详情]

向TA提问

程云阁

主任医师 副教授

擅长:胸腔镜 [详情]

向TA提问

常见用药

补中益气丸

[功能主治]色欲伤,腹股沟直疝,腹股....详情

元胡止痛片

[功能主治]理气,活血,止痛。用于行...详情

小儿泻止散

[功能主治]小儿湿热内蕴,非感染性轻...详情

推荐医院

暨南大学医学院附属黄埔区中医院

暨南大学医学院附属黄埔区中医院

二级甲等/综合医院/医保定点

广州市黄埔区蟹山路3号

中国人民解放军空军航空医学研究所附属医院

中国人民解放军空军航空医学研究所附属医院

三级甲等/综合医院/医保定点

北京市海淀区昌运宫15号

哈尔滨第一医院

哈尔滨第一医院

三级甲等/综合医院/医保定点

哈尔滨市道里区地段街151号

猜你喜欢

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Copyright© 2000-2015 www.9939.com All Rights Reserved 版权所有 皖ICP备18005611号-7

特别声明:本站信息仅供参考 不能作为诊断及医疗的依据 本站如有转载或引用文章涉及版权问题请速与我们联系